SOHM Inc, a generic pharmaceutical manufacturer, has launched 26 branded generic pharmaceutical products in India. SOHM's newly launched products included two powerful and highly consumed antibiotics for respiratory diseases. SOHM has also launched anti-colds, anti-asthmatics, and cough suppressant products. These products will be manufactured by SOHM's facilities in India with immediate market ...

Halozyme Therapeutics, Inc has started a phase 1 clinical study its proprietary ultrafast rHuPH20 (PH20) hyaluronidase enzyme across three approved prandial (mealtime) insulin analogs.

Stelara (ustekinumab) marketed by Janssen-Ortho Inc has been approved for the treatment of moderate to severe plaque psoriasis in adults by USFDA.

PF-02341066, a new drug to treat advanced non-small cell lung cancer, from Pfizer will soon go for  Phase 3 clinical studies.

Vomiting drug Zunrisa/Rezonic (casopitant) filings of marketing applications worldwide have been withdrawn by GlaxoSmithKline as the drug need more data on its safety.

88 pancreatitis cases linked with Januvia reported, so far. Januvia was launched in India in 2008

Glenmark Pharmaceuticals Ltd may sell a portion of its stake in generic unit Glenmark Generic to raise fund to service mounting debts, reports said.

Indian pharma companies export drug products to more than 150 countries

Strides Arcolab has launched Starflu - the company's generic version of H1N1 swine flu drug oseltamivir (Tamiflu) in India.

Drug manufacturers with valid product licences issued by state authorities can use them till expiry